EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

DSwiss Inc (DQWS) fair value: what the stock is really worth

We calculate from audited financials what DSwiss Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jun 23, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Consumer Defensive · US

DI DSwiss Inc logo Thin data Jun 23, 2026

DSwiss Inc

DQWS · US

Weakest SetupStrongly overvalued and low quality.

!Fair value $0.0200 · Strongly overvalued (−76%)
!Quality 47/100
!Expensive Growth (revenue 5y +16.7 %/yr)
!Loss-making · -8.8% net margin (TTM)
!Negative equity (buybacks among others) · negative free cash flow
!Trails peers (0/7)
!Narrow moat 12/100
!Evidence only low, so the estimate is less certain

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$42.00 $0.0067 Fair Value $0.0200 Jun 2017 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 23, 2026.

How to read this chart

60‑month range $0.0067 – $42.00 · fair‑value band $0.0200 – $0.0300 · the $0.0840 price screens above the $0.0200 fair value. Dashed = 300-day average. As of Jun 23, 2026.

Follow DSwiss in your weekly email

Every Wednesday you see whether DSwiss is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers.

Show more

DSwiss, Inc., a biotech nutraceutical company, provides healthcare, skincare, and personal care products in Malaysia, Singapore, Indonesia, Australia, Hong Kong, Taiwan, Macau, and China. It supplies health and beauty products, including weight management beverages, anti-aging creams, and immune system enhancers. The company also provides private label manufacturing services for nutraceutical and skincare/personal care ODM/OEM products; pet wellness supplements; and pet-care products, as well as medical consumable supplies, such as disposable stretcher cover and bedsheet, masks, body infrared thermometers, sanitizer, protective goggles, surgical gloves, isolation suit, industrial disinfectant, and protection surgical and medical gown. In addition, it offers OEM/ODM/OBM services, such as DSwiss quantum magnetic analyzer and DNA genotyping services; Eyecare; and biotechnology research channel services. DSwiss, Inc. was incorporated in 2015 and is headquartered in Kuala Lumpur, Malaysia.

Stock analysis

DSwiss Inc (DQWS) currently trades at $0.0840, while our model-based Fair Value estimate is $0.0200, implying the stock looks roughly 320.0% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 3 models at a data quality of 95/100, which puts the evidence level at low.

Scenario range: $0.0200 (bear) to $0.0300 (bull), the price of $0.0840 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

DSwiss Inc reported revenue of $2.9M in FY2025 versus $2.0M in FY2021, a compound +10.5%/yr. Reported net income was −$76.9K in FY2025.

Key figures

Market cap $17.4M · P/S ratio 3.62 · Net margin −2.6% · Return on equity −204% · Return on assets (EBIT) 1.5% · Operating margin 2.2% · Revenue (TTM) $2.4M · Revenue growth (YoY) −52.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (medium confidence).

What moves the price

The share trades about 1% below its 52-week high and 277% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at −14% fair-value upside, at −76%, DQWS screens richer than that median.

Notify me when DQWS reaches fair value

Put DQWS on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 47/100

Of which business quality 50 · Market factors (momentum, volatility) 59

Profitability 50
Margins and returns on capital today
Quality Growth 17
Are margins and returns improving?
Cashflow 18
Earnings quality: real cash, not paper profit
Fin. Strength 75
Balance sheet, leverage, solvency risk
Investment 67
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 67
Price trend over the last 3–12 months (market factor)
52W Momentum 57
Distance to the 52-week high (market factor)
Net Issuance 82
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 38/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−6.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.7%
Start year 2020 (pandemic). Over 10 years: +34.1% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+15.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
10.2% (2020) → −2.9% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

DQWS screens 320% overvalued. Compare with Colgate-Palmolive Company →

Compare DSwiss Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 251 stocks

Beats the industry median on 0/7 measures
Overall it trails its industry peers.
Valuation
Quality Score 47 · Bottom 25%
Fair Value upside −76% · Bottom 25%
Profitability
Return on equity (TTM) Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets −18% · Bottom 25%
Net margin (TTM) −9% · Bottom 25%
Operating margin (TTM) 2% · Below median
Growth and dividend
Revenue growth −52% · Bottom 25%
Balance sheet
Debt / equity Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.

Valuation Multiplesvs Household & Personal Products median · lower = cheaper

P/B Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM) 7.25× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Colgate-Palmolive Company CL $85.93 $55.95 −35%
Hindustan Unilever Limited HINDUNILVR ₹1,950 ₹775.25 −60%
Kenvue Inc KVUE $17.86 $12.73 −29%
Kimberly-Clark Corporation KMB $97.70 $83.93 −14%
Henkel AG HEN €68.50 €80.96 +18%
The Estée Lauder Companies Inc EL $98.83 $27.22 −72%
Church & Dwight Co CHD $96.02 $65.12 −32%
Beiersdorf Aktiengesellschaft, BEI €78.18 €68.95 −12%
Puig Brands, S.A PUIG €17.56 €19.32 +10%
The Clorox Company CLX $87.15 $104.53 +20%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "DSwiss Inc Fair Value". https://www.fairvalue-calculator.com/stock/DQWS

Frequently asked questions

Is DSwiss Inc (DQWS) overvalued or undervalued?
As of Jun 23, 2026, our model estimates a fair value of $0.0200 versus a price of $0.0840, about −76% upside (overvalued).
What is the fair value of DQWS?
Our model-based fair value for DSwiss Inc is $0.0200 (as of Jun 23, 2026), built from audited fundamentals. The current price: $0.0840.
What is the quality score of DQWS?
DSwiss Inc has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for DSwiss Inc (DQWS)?
Our model-based price target is the fair value of $0.0200 (as of Jun 23, 2026) from 3 valuation models. Cautious scenario $0.0200, optimistic scenario $0.0300. It is a calculation from audited fundamentals, not an analyst target.
What is the DSwiss Inc stock forecast for 2026?
Our models put fair value at $0.0200, about −76% upside versus a price of $0.0840 (overvalued). Cautious scenario $0.0200, optimistic scenario $0.0300. The calculation is refreshed regularly with new filings.
What is the revenue of DSwiss Inc (DQWS)?
DSwiss Inc reported trailing-twelve-month revenue of about $2.4M (latest available figure, as of Jun 23, 2026).
What is the intrinsic value of DSwiss Inc (DQWS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For DSwiss Inc it is $0.0200 per share (as of Jun 23, 2026), against a price of $0.0840. It is the blended result of 3 valuation models (cash flow, earnings, asset, dividend).
Is DSwiss Inc stock overvalued or undervalued in 2026?
As of Jun 23, 2026, DQWS trades above its calculated fair value: price $0.0840, fair value $0.0200, a gap of about −76% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of DQWS?
No. The price is what the market pays today ($0.0840); the fair value is what the company's own numbers justify ($0.0200). For DSwiss Inc the two are $0.0640 per share apart. That gap is exactly why we show both numbers side by side.
How much is DSwiss Inc worth?
The market values DSwiss Inc at about $17.4M (market capitalisation, as of Jun 23, 2026). Per share that is $0.0840; our models calculate a fair value of $0.0200 per share.
What do the bullish and bearish scenarios say about DQWS?
Our models span a range for DSwiss Inc: cautious scenario $0.0200, base $0.0200, optimistic $0.0300 per share (as of Jun 23, 2026, price $0.0840). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of DSwiss Inc (DQWS)?
Balance-sheet figures for DSwiss Inc (as of Jun 23, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 47/100, which measures business quality independently of the share price.
How far is DQWS from its 52-week high?
DSwiss Inc trades at $0.0840, about 1% below its 52-week high of $0.0850 and 277% above the low of $0.0223 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0200 is for.
Which stocks are comparable to DSwiss Inc?
From the same area (Consumer Defensive) we also value Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, Kimberly-Clark Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is DSwiss Inc stock attractive at the current price?
The data as of Jun 23, 2026: price $0.0840, calculated fair value $0.0200 (−76%), Quality Score 47/100, from 3 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of DQWS calculated?
We run DSwiss Inc through 3 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0200, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. DSwiss Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of DSwiss Inc (DQWS)?
The closing price on Sep 23, 2026 was $0.0840. Our model-based fair value is $0.0200, about −76% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with DSwiss Inc right now?
The price sits above even our optimistic bull case ($0.0300). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.

Key figures of DSwiss Inc

How large is the market capitalisation of DSwiss Inc (DQWS)?
The market capitalisation of DSwiss Inc is $17.4M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of DSwiss Inc (DQWS)?
The price-to-sales ratio of DSwiss Inc is 3.62 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of DSwiss Inc (DQWS)?
The net margin of DSwiss Inc is −2.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of DSwiss Inc (DQWS)?
The return on equity (ROE) of DSwiss Inc is −204% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of DSwiss Inc (DQWS)?
On an EBIT basis the return on assets of DSwiss Inc is 1.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of DSwiss Inc (DQWS)?
The operating margin of DSwiss Inc is 2.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at DSwiss Inc (DQWS)?
Revenue at DSwiss Inc is growing −52.3% versus a year earlier (3y avg +16.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at DSwiss Inc (DQWS)?
Earnings per share at DSwiss Inc are growing −97.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does DSwiss Inc (DQWS) generate?
The free cash flow of DSwiss Inc is −$135K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does DSwiss Inc (DQWS) hold?
DSwiss Inc holds more cash than debt, $2.8K net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch DSwiss Inc in the live analysis

One click puts DSwiss Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.